Sodium Chloride Tablets
- Manufacturer
- Wittman Pharma, Inc.
- Effective date
- 2024-04-04
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 00:10:46
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
DOSAGE & ADMINISTRATION SECTION
Directions
- to make isontonic solution of sodium chloride, dissolve one tablet in 120 ml (four ounces) of distilled water and use as directed by a physician.
- if used as an electrolyte replenisher for the prevention of heat cramps due to excessive perspiration take one tablet orally as directed by your physician.
WARNINGS SECTION
Warnings
Do not use without consulting a physician
Ask a physician before use if you have a sodium restricted diet due to multiple organ diseases
Stop use and ask a physician if symptoms of heat cramps continue for more than 24 hours.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
INACTIVE INGREDIENT SECTION
None
INDICATIONS & USAGE SECTION
Uses
- for the preparation of normal isotonic solution of sodium chloride
- as an electrolyte replenisher for the prevention of heat cramps due to excessive perspiration
- any alternative use as directed by a physician
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
OTC - PURPOSE SECTION
Purpose
Electrolyte Replenisher
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Sodium Chloride, USP 1.0 gram
Drug Facts
Active ingredient (in each tablet)
Sodium Chloride, USP 1.0 gram
Purpose
Electrolyte Replenisher
Uses
- for the preparation of normal isotonic solution of sodium chloride
- as an electrolyte replenisher for the prevention of heat cramps due to excessive perspiration
- any alternative use as directed by a physician
Warnings
Do not use without consulting a physician
Ask a physician before use if you have a sodium restricted diet due to multiple organ diseases
Stop use and ask a physician if symptoms of heat cramps continue for more than 24 hours.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- to make isontonic solution of sodium chloride, dissolve one tablet in 120 ml (four ounces) of distilled water and use as directed by a physician.
- if used as an electrolyte replenisher for the prevention of heat cramps due to excessive perspiration take one tablet orally as directed by your physician.
Other information
- each tablet contains: sodium 394 mg
- store at room temperature 15°-30°C (59°-86°F)
- product does not contain any inactive ingredients
Questions or comments?
Call 1-352-549-9917 M-F 9am - 5pm EST
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 83335-002-01 | 2025-07-29 | C162847 | 48780-1 | 3b156c62-30c8-fb37-e063-e6dba90a4e07 | Sodium Chloride Tablets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83335-002-01 | Sodium Chloride | 100 g in 1 BOTTLE | TABLET | 100 | 3 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Sodium Chloride
- Normal Salt Tablets
- CHLORIDE ION
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 83335-002 | 83335-002-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 154806ed-91ac-fc7f-e063-6294a90ae0f4 | 027fd7db-c06f-3245-e063-6294a90af540 | 2024-04-04 | Warnings | 154806ed-91ac-fc7f-e063-6294a90ae0f4 027fd7db-c06f-3245-e063-6294a90af540 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
